LISDEXAMFETAMINE

LISDEXAMFETAMINE was reported 33463 times

LISDEXAMFETAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GAMING DISORDER 3 0.1579
1 CREATINE KINASE ABNORMAL 3 0.1250
2 STEROID DEPENDENCE 106 0.1207
3 ANTI-TRANSGLUTAMINASE ANTIBODY INCREASED 7 0.1207
4 CATARRH 106 0.1173
5 ORTHODONTIC PROCEDURE 6 0.1111
6 DECREASED EYE CONTACT 30 0.0987
7 ADRENERGIC SYNDROME 7 0.0864
8 OPPOSITIONAL DEFIANT DISORDER 33 0.0835
9 PREMENSTRUAL DYSPHORIC DISORDER 14 0.0690
10 SEXUAL INHIBITION 6 0.0645
11 BURNS SECOND DEGREE 107 0.0609
12 RABBIT SYNDROME 9 0.0542
13 CHOREOATHETOSIS 36 0.0530
14 INTENTIONAL SELF-INJURY 1047 0.0518
15 SELECTIVE MUTISM 4 0.0476
16 DRUG METABOLITE LEVEL HIGH 4 0.0476
17 ADULTERATED PRODUCT 9 0.0450
18 EXECUTIVE DYSFUNCTION 24 0.0443
19 SYMPATHOMIMETIC EFFECT 10 0.0433
20 SACCADIC EYE MOVEMENT 7 0.0419
21 DISRUPTIVE MOOD DYSREGULATION DISORDER 3 0.0405
22 INABILITY TO AFFORD MEDICATION 400 0.0402
23 FOETAL ALCOHOL SYNDROME 4 0.0400
24 CHANGE IN SUSTAINED ATTENTION 12 0.0399
25 WHITE BLOOD CELLS URINE 11 0.0396
26 DYSANIA 3 0.0390
27 PICA 7 0.0389
28 ALCOHOL POISONING 100 0.0373
29 ORGANIC BRAIN SYNDROME 7 0.0372
30 SENSORY OVERLOAD 7 0.0355
31 SUBCHORIONIC HAEMATOMA 6 0.0341
32 DELUSION OF PARASITOSIS 5 0.0318
33 HYPOPNOEA 106 0.0305
34 POLYDIPSIA PSYCHOGENIC 6 0.0293
35 ACUTE MACULAR NEURORETINOPATHY 5 0.0292
36 ACCELERATED IDIOVENTRICULAR RHYTHM 4 0.0270
37 VEIN DISCOLOURATION 12 0.0255
38 THERAPEUTIC RESPONSE CHANGED 152 0.0240
39 OPSOCLONUS MYOCLONUS 5 0.0235
40 PNEUMOPERICARDIUM 4 0.0233
41 BINGE EATING 24 0.0222
42 PRODUCT AVAILABILITY ISSUE 506 0.0222
43 AMNIORRHOEA 4 0.0211
44 SUICIDE THREAT 8 0.0205
45 ELECTROCARDIOGRAM CHANGE 19 0.0200
46 THERAPEUTIC PRODUCT EFFECT VARIABLE 75 0.0193
47 VENTRICULAR DYSKINESIA 4 0.0192
48 AUTISM SPECTRUM DISORDER 103 0.0187
49 ANISOCORIA 7 0.0185
50 SOCIAL ANXIETY DISORDER 12 0.0183
51 INSURANCE ISSUE 269 0.0176
52 INTENTIONAL OVERDOSE 1099 0.0171
53 COMPULSIONS 11 0.0165
54 ATTENTION DEFICIT HYPERACTIVITY DISORDER 69 0.0164
55 SELF-DESTRUCTIVE BEHAVIOUR 14 0.0161
56 SUSPECTED PRODUCT TAMPERING 9 0.0160
57 BODY DYSMORPHIC DISORDER 6 0.0160
58 BRONCHIECTASIS 106 0.0157
59 TRICHOTILLOMANIA 9 0.0154
60 DERMATILLOMANIA 9 0.0151
61 HYPERTENSIVE URGENCY 8 0.0144
62 PAROSMIA 109 0.0144
63 TIME PERCEPTION ALTERED 5 0.0138
64 RHINITIS 109 0.0135
65 GINGIVAL PAIN 107 0.0134
66 DEFIANT BEHAVIOUR 4 0.0130
67 DRUG TOLERANCE INCREASED 10 0.0128
68 CARDIAC MURMUR 107 0.0124
69 JOB DISSATISFACTION 8 0.0123
70 MEAN PLATELET VOLUME DECREASED 10 0.0119
71 HYPERTENSIVE EMERGENCY 14 0.0119
72 HYPONATRAEMIC SEIZURE 3 0.0118
73 BOREDOM 4 0.0118
74 PRODUCT MONITORING ERROR 17 0.0118
75 RECALLED PRODUCT ADMINISTERED 111 0.0116
76 ABDOMINAL LYMPHADENOPATHY 10 0.0115
77 NEURODEGENERATIVE DISORDER 7 0.0113
78 DRUG-GENETIC INTERACTION 4 0.0112
79 ANION GAP 7 0.0110
80 INTRUSIVE THOUGHTS 13 0.0110
81 THYROXINE FREE DECREASED 6 0.0106
82 THEFT 7 0.0105
83 AVERSION 3 0.0104
84 BLUE TOE SYNDROME 4 0.0102
85 ALCOHOL INTOLERANCE 7 0.0099
86 DISSOCIATIVE DISORDER 7 0.0097
87 BRUXISM 52 0.0096
88 EOSINOPHILIC PNEUMONIA ACUTE 8 0.0092
89 SENSITISATION 7 0.0092
90 MITE ALLERGY 6 0.0092
91 IMPULSIVE BEHAVIOUR 34 0.0091
92 DRUG EFFECT FASTER THAN EXPECTED 3 0.0090
93 PERINATAL DEPRESSION 4 0.0089
94 GROWTH FAILURE 3 0.0087
95 BASAL GANGLIA HAEMORRHAGE 7 0.0086
96 INTELLECTUAL DISABILITY 13 0.0086
97 PRODUCT SUBSTITUTION ISSUE 482 0.0084
98 BACTERIAL DISEASE CARRIER 6 0.0082
99 MONOCYTE COUNT DECREASED 10 0.0082
100 HYPERKINESIA 17 0.0080
101 WATER INTOXICATION 4 0.0079
102 HOMICIDAL IDEATION 32 0.0079
103 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 13 0.0078
104 IMPAIRED QUALITY OF LIFE 112 0.0078
105 EMOTIONAL POVERTY 13 0.0074
106 BRAIN FOG 115 0.0073
107 DRUG EFFECT LESS THAN EXPECTED 107 0.0072
108 TRISMUS 37 0.0072
109 TIC 39 0.0071
110 PRODUCT PHYSICAL ISSUE 143 0.0071
111 DISORGANISED SPEECH 13 0.0070
112 BURNOUT SYNDROME 4 0.0070
113 NARCOLEPSY 13 0.0069
114 BODY MASS INDEX DECREASED 3 0.0065
115 IMPAIRED WORK ABILITY 138 0.0064
116 STRESS CARDIOMYOPATHY 37 0.0064
117 FOREIGN BODY IN EYE 6 0.0063
118 CHRONIC HEPATITIS 5 0.0062
119 TUBULOINTERSTITIAL NEPHRITIS 114 0.0061
120 DISTRACTIBILITY 7 0.0061
121 SPUTUM ABNORMAL 4 0.0060
122 FOOD INTERACTION 10 0.0057
123 OCULOGYRIC CRISIS 12 0.0056
124 LANGUAGE DISORDER 12 0.0055
125 SUSPECTED PRODUCT QUALITY ISSUE 10 0.0055
126 AMPHETAMINES POSITIVE 4 0.0053
127 ENCEPHALITIS AUTOIMMUNE 7 0.0053
128 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 7 0.0052
129 HYPERVIGILANCE 5 0.0052
130 NEAR DEATH EXPERIENCE 17 0.0051
131 DRUG TOLERANCE 26 0.0051
132 SUSPECTED SUICIDE 24 0.0051
133 CULTURE URINE POSITIVE 7 0.0050
134 HEAT EXHAUSTION 4 0.0050
135 FEELING OF DESPAIR 23 0.0049
136 KNEE DEFORMITY 7 0.0047
137 ACTIVITIES OF DAILY LIVING DECREASED 3 0.0047
138 SEROTONIN SYNDROME 90 0.0047
139 MENTAL FATIGUE 7 0.0047
140 ELECTRIC SHOCK SENSATION 13 0.0046
141 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 222 0.0046
142 DISTURBANCE IN ATTENTION 249 0.0046
143 HEAT STROKE 7 0.0046
144 AFFECT LABILITY 44 0.0046
145 CARDIAC OUTPUT DECREASED 4 0.0045
146 VULVOVAGINAL CANDIDIASIS 6 0.0044
147 STRESS AT WORK 5 0.0044
148 PNEUMOMEDIASTINUM 8 0.0044
149 METABOLIC SURGERY 5 0.0044
150 FEELING OF RELAXATION 3 0.0044
151 HYPERSEXUALITY 8 0.0044
152 IMPULSE-CONTROL DISORDER 9 0.0044
153 BEZOAR 6 0.0043
154 DISTURBANCE IN SEXUAL AROUSAL 4 0.0043
155 HAND DERMATITIS 3 0.0043
156 FREQUENT BOWEL MOVEMENTS 117 0.0043
157 STREPTOCOCCAL INFECTION 24 0.0043
158 HYPERPHAGIA 17 0.0043
159 EDUCATIONAL PROBLEM 7 0.0042
160 HAEMORRHAGE IN PREGNANCY 6 0.0042
161 IRRITABILITY 250 0.0042
162 PATIENT DISSATISFACTION WITH TREATMENT 8 0.0041
163 BLOOD IMMUNOGLOBULIN G INCREASED 5 0.0041
164 TOBACCO USER 6 0.0040
165 INDIFFERENCE 3 0.0040
166 APATHY 58 0.0040
167 BASOPHIL COUNT INCREASED 3 0.0040
168 DILATED CARDIOMYOPATHY 4 0.0040
169 ABORTION MISSED 5 0.0039
170 DISSOCIATION 30 0.0039
171 FLAT AFFECT 9 0.0039
172 SWOLLEN TONGUE 121 0.0039
173 TUNNEL VISION 7 0.0037
174 PSYCHOMOTOR HYPERACTIVITY 62 0.0037
175 LOGORRHOEA 13 0.0037
176 TROPONIN I INCREASED 6 0.0036
177 FACIAL SPASM 4 0.0036
178 MAST CELL ACTIVATION SYNDROME 5 0.0036
179 STATUS EPILEPTICUS 40 0.0035
180 BEHAVIOUR DISORDER 19 0.0035
181 CARDIOGENIC SHOCK 50 0.0035
182 SERUM FERRITIN DECREASED 6 0.0035
183 TACHYPHRENIA 12 0.0035
184 PSYCHOTIC SYMPTOM 7 0.0034
185 OBSESSIVE THOUGHTS 6 0.0033
186 SLEEP DEFICIT 7 0.0033
187 BIPOLAR DISORDER 36 0.0033
188 COORDINATION ABNORMAL 46 0.0033
189 NIGHTMARE 114 0.0033
190 THERAPEUTIC PRODUCT EFFECT DELAYED 15 0.0033
191 MYDRIASIS 42 0.0033
192 PREMATURE SEPARATION OF PLACENTA 5 0.0032
193 SUICIDAL IDEATION 296 0.0032
194 HYPERACUSIS 12 0.0032
195 SUBSTANCE USE 5 0.0032
196 PRODUCT FORMULATION ISSUE 21 0.0032
197 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0032
198 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 7 0.0031
199 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
200 CORNEAL OEDEMA 7 0.0031
201 DEPRESSIVE SYMPTOM 11 0.0031
202 OBSESSIVE-COMPULSIVE DISORDER 25 0.0031
203 SYSTEMIC LUPUS ERYTHEMATOSUS 110 0.0031
204 HALLUCINATIONS, MIXED 13 0.0031
205 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 19 0.0031
206 COUNTERFEIT PRODUCT ADMINISTERED 4 0.0031
207 SEXUAL DYSFUNCTION 36 0.0031
208 ACCIDENTAL OVERDOSE 112 0.0031
209 POISONING DELIBERATE 29 0.0031
210 SUSPECTED COUNTERFEIT PRODUCT 12 0.0030
211 ANTISOCIAL BEHAVIOUR 3 0.0030
212 FRUSTRATION TOLERANCE DECREASED 24 0.0030
213 TORSADE DE POINTES 23 0.0029
214 CLONUS 8 0.0029
215 PREMENSTRUAL SYNDROME 4 0.0029
216 PULSE ABNORMAL 7 0.0029
217 SUICIDAL BEHAVIOUR 12 0.0029
218 CARDIAC FAILURE ACUTE 19 0.0028
219 MEDICATION ERROR 158 0.0028
220 EUPHORIC MOOD 29 0.0028
221 ACUTE PSYCHOSIS 7 0.0028
222 TACHYARRHYTHMIA 7 0.0028
223 PRODUCT TAMPERING 5 0.0028
224 DEPRESSED MOOD 147 0.0028
225 AGGRESSION 139 0.0028
226 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 3 0.0028
227 BLADDER DILATATION 3 0.0028
228 JUDGEMENT IMPAIRED 4 0.0028
229 GENERALISED ANXIETY DISORDER 4 0.0027
230 HYPOMANIA 10 0.0027
231 RECTAL HAEMORRHAGE 116 0.0027
232 TINNITUS 123 0.0027
233 AFFECTIVE DISORDER 21 0.0027
234 FEAR OF DEATH 6 0.0027
235 LOSS OF EMPLOYMENT 8 0.0026
236 SELF-INJURIOUS IDEATION 11 0.0026
237 HYPERREFLEXIA 9 0.0026
238 DISCOURAGEMENT 6 0.0026
239 JAW DISORDER 14 0.0026
240 COLITIS ULCERATIVE 114 0.0025
241 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 5 0.0025
242 MYOPIA 6 0.0025
243 ANGER 85 0.0025
244 ALLERGIC REACTION TO EXCIPIENT 5 0.0025
245 BRONCHIAL HYPERREACTIVITY 3 0.0025
246 MANIA 41 0.0025
247 ECZEMA 128 0.0024
248 METABOLIC SYNDROME 4 0.0024
249 OVERWEIGHT 13 0.0024
250 AKATHISIA 33 0.0024
251 NEGATIVE THOUGHTS 7 0.0024
252 PERSONALITY CHANGE 22 0.0024
253 TORTICOLLIS 5 0.0024
254 WITHDRAWAL SYNDROME 99 0.0024
255 METABOLIC ENCEPHALOPATHY 7 0.0023
256 TEARFULNESS 10 0.0023
257 PRODUCT COUNTERFEIT 4 0.0023
258 CRANIOCEREBRAL INJURY 7 0.0023
259 PRODUCT ADMINISTRATION INTERRUPTED 18 0.0023
260 DRUG SCREEN NEGATIVE 4 0.0023
261 FEELING JITTERY 43 0.0023
262 DRUG WITHDRAWAL CONVULSIONS 4 0.0022
263 YAWNING 6 0.0022
264 AGITATION 165 0.0022
265 ANION GAP INCREASED 3 0.0022
266 TEMPERATURE REGULATION DISORDER 5 0.0022
267 ANORGASMIA 6 0.0022
268 HAEMATOCHEZIA 122 0.0022
269 THERAPEUTIC RESPONSE DECREASED 134 0.0022
270 ACUTE HEPATIC FAILURE 30 0.0022
271 AGORAPHOBIA 3 0.0022
272 SINUS TACHYCARDIA 31 0.0022
273 SOCIAL PROBLEM 9 0.0022
274 HEART RATE ABNORMAL 12 0.0021
275 CARDIAC DYSFUNCTION 8 0.0021
276 CRYING 78 0.0021
277 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 11 0.0021
278 PALPITATIONS 249 0.0021
279 GLUTEN SENSITIVITY 3 0.0021
280 HYPERCOAGULATION 4 0.0021
281 MOOD ALTERED 57 0.0021
282 POOR QUALITY PRODUCT ADMINISTERED 22 0.0021
283 SOCIAL AVOIDANT BEHAVIOUR 12 0.0021
284 SUICIDE ATTEMPT 124 0.0020
285 VERTIGO 124 0.0020
286 UNDERWEIGHT 4 0.0020
287 DROOLING 14 0.0020
288 POLYMENORRHOEA 7 0.0020
289 THINKING ABNORMAL 37 0.0020
290 VITAMIN B12 DEFICIENCY 8 0.0020
291 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
292 APPETITE DISORDER 13 0.0020
293 POOR QUALITY SLEEP 42 0.0019
294 REBOUND EFFECT 22 0.0019
295 DAYDREAMING 3 0.0019
296 PANIC REACTION 14 0.0019
297 PERFORMANCE STATUS DECREASED 9 0.0019
298 MONOCYTE COUNT INCREASED 7 0.0019
299 INSULIN RESISTANCE 4 0.0019
300 PARANOIA 33 0.0019
301 INHIBITORY DRUG INTERACTION 3 0.0019
302 INAPPROPRIATE AFFECT 3 0.0019
303 DEREALISATION 4 0.0019
304 VULVOVAGINAL DRYNESS 6 0.0019
305 MIGRAINE 176 0.0018
306 HUNGER 25 0.0018
307 PSYCHOTIC DISORDER 53 0.0018
308 ILEUS PARALYTIC 8 0.0018
309 DRUG DIVERSION 11 0.0018
310 DYSPHORIA 9 0.0018
311 POLYDIPSIA 7 0.0018
312 EROSIVE OESOPHAGITIS 3 0.0018
313 FOOD AVERSION 3 0.0018
314 ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE 3 0.0018
315 NEUTROPHIL COUNT INCREASED 18 0.0018
316 CEREBRAL ATROPHY 7 0.0018
317 PRODUCT COLOUR ISSUE 9 0.0018
318 HAIR GROWTH ABNORMAL 12 0.0017
319 KIDNEY FIBROSIS 3 0.0017
320 VOMITING PROJECTILE 5 0.0017
321 DEEP VEIN THROMBOSIS 111 0.0017
322 MUSCLE CONTRACTIONS INVOLUNTARY 6 0.0017
323 RESTLESS LEGS SYNDROME 31 0.0017
324 ANXIETY 475 0.0017
325 HEAVY MENSTRUAL BLEEDING 15 0.0017
326 WEIGHT ABNORMAL 4 0.0017
327 LEARNING DISORDER 4 0.0017
328 THERAPEUTIC RESPONSE SHORTENED 55 0.0017
329 WRONG DOSE 4 0.0017
330 DEPRESSION 376 0.0017
331 MAJOR DEPRESSION 12 0.0016
332 BREATH ODOUR 4 0.0016
333 CONDUCTION DISORDER 3 0.0016
334 HALLUCINATION, AUDITORY 26 0.0016
335 EMOTIONAL DISORDER 50 0.0016
336 IMPATIENCE 3 0.0016
337 DYSGEUSIA 118 0.0016
338 EXPOSURE VIA INGESTION 4 0.0016
339 THERAPEUTIC PRODUCT EFFECT DECREASED 71 0.0016
340 RETINAL ARTERY OCCLUSION 4 0.0016
341 HYPERAESTHESIA 13 0.0016
342 IRIDOCYCLITIS 5 0.0016
343 EXPOSURE TO TOXIC AGENT 5 0.0016
344 PANIC DISORDER 6 0.0015
345 CONVERSION DISORDER 3 0.0015
346 PRODUCT SUPPLY ISSUE 11 0.0015
347 RESTLESSNESS 56 0.0015
348 SEDATION 40 0.0015
349 PERSONALITY DISORDER 4 0.0015
350 DYSKINESIA 62 0.0015
351 ADVERSE DRUG REACTION 136 0.0015
352 MOOD SWINGS 48 0.0015
353 GASTRITIS EROSIVE 7 0.0015
354 ARTERIOSPASM CORONARY 6 0.0015
355 CARDIAC DISCOMFORT 3 0.0015
356 MUSCLE TIGHTNESS 24 0.0015
357 GAMBLING DISORDER 4 0.0015
358 SLEEP DISORDER 104 0.0015
359 SOMNOLENCE 292 0.0014
360 PLEURITIC PAIN 4 0.0014
361 DRUG-INDUCED LIVER INJURY 45 0.0014
362 MUSCLE TWITCHING 33 0.0014
363 DRUG TOLERANCE DECREASED 4 0.0014
364 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
365 HANGOVER 5 0.0014
366 INTENTIONAL PRODUCT USE ISSUE 124 0.0014
367 MENTAL DISORDER 61 0.0014
368 NEUROLOGICAL SYMPTOM 8 0.0014
369 DYSTONIA 27 0.0014
370 PRODUCT SOLUBILITY ABNORMAL 7 0.0014
371 ARTHRITIS 109 0.0014
372 PRODUCT USE ISSUE 260 0.0014
373 METABOLIC DISORDER 8 0.0014
374 UTERINE LEIOMYOMA 10 0.0014
375 BIPOLAR I DISORDER 3 0.0014
376 ACCIDENT AT WORK 3 0.0014
377 POISONING 17 0.0014
378 ABNORMAL BEHAVIOUR 53 0.0013
379 COMPLETED SUICIDE 111 0.0013
380 DRUG INTERACTION 211 0.0013
381 MENTAL IMPAIRMENT 32 0.0013
382 PERIPHERAL COLDNESS 18 0.0013
383 COMMUNICATION DISORDER 5 0.0013
384 RESPIRATORY DEPRESSION 16 0.0013
385 FORMICATION 9 0.0013
386 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 232 0.0013
387 HEPATIC ENCEPHALOPATHY 12 0.0013
388 EPSTEIN-BARR VIRUS INFECTION 8 0.0013
389 SLUGGISHNESS 13 0.0013
390 TACHYCARDIA 113 0.0013
391 QUALITY OF LIFE DECREASED 17 0.0013
392 ANGIOPATHY 7 0.0012
393 MIOSIS 10 0.0012
394 CONFUSIONAL STATE 201 0.0012
395 NEUTROPHILIA 7 0.0012
396 LYMPHOCYTE COUNT INCREASED 4 0.0012
397 THERAPY PARTIAL RESPONDER 19 0.0012
398 LISTLESS 4 0.0012
399 FEELING DRUNK 9 0.0012
400 PULMONARY EMBOLISM 114 0.0012
401 HYPOTHERMIA 12 0.0012
402 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
403 PRODUCT LABEL ISSUE 8 0.0012
404 HYPERTHERMIA 9 0.0012
405 TONGUE DISCOMFORT 5 0.0012
406 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 8 0.0012
407 HEPATIC PAIN 5 0.0012
408 VITAMIN D DECREASED 10 0.0012
409 INITIAL INSOMNIA 12 0.0012
410 ALCOHOLISM 5 0.0012
411 CEREBRAL ISCHAEMIA 6 0.0012
412 SPEECH DISORDER 61 0.0012
413 DELUSION 18 0.0012
414 DEPRESSION SUICIDAL 4 0.0012
415 SCHIZOPHRENIA 14 0.0012
416 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7 0.0011
417 VENTRICULAR TACHYCARDIA 19 0.0011
418 PLATELET COUNT INCREASED 15 0.0011
419 TENSION 7 0.0011
420 MALABSORPTION 6 0.0011
421 DYSPHEMIA 5 0.0011
422 INSOMNIA 303 0.0011
423 CARDIOTOXICITY 10 0.0011
424 DISABILITY 22 0.0011
425 ELECTROCARDIOGRAM QT PROLONGED 40 0.0011
426 CLUMSINESS 3 0.0011
427 CONDITION AGGRAVATED 334 0.0011
428 VENTRICULAR ARRHYTHMIA 4 0.0011
429 RESPIRATORY ARREST 30 0.0011
430 DRUG LEVEL INCREASED 18 0.0011
431 TOXICITY TO VARIOUS AGENTS 183 0.0011
432 PRODUCT PHYSICAL CONSISTENCY ISSUE 6 0.0011
433 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
434 CARDIAC FLUTTER 7 0.0011
435 INTERMENSTRUAL BLEEDING 6 0.0011
436 SNORING 4 0.0011
437 AUTOIMMUNE THYROIDITIS 4 0.0011
438 MICTURITION URGENCY 12 0.0010
439 THERAPY INTERRUPTED 75 0.0010
440 ENDOMETRIOSIS 5 0.0010
441 POST-TRAUMATIC STRESS DISORDER 7 0.0010
442 PANIC ATTACK 38 0.0010
443 MOUTH SWELLING 6 0.0010
444 HEART RATE INCREASED 103 0.0010
445 BLOOD PARATHYROID HORMONE INCREASED 3 0.0010
446 APHASIA 31 0.0010
447 BRADYKINESIA 6 0.0010
448 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
449 FEAR 27 0.0010
450 HEPATIC ENZYME ABNORMAL 5 0.0010
451 ARRHYTHMIA 47 0.0010
452 FEELING ABNORMAL 237 0.0010
453 PRODUCT TEMPERATURE EXCURSION ISSUE 5 0.0010
454 PHARYNGITIS 12 0.0010
455 COLD SWEAT 17 0.0010
456 CARDIO-RESPIRATORY ARREST 40 0.0010
457 ABDOMINAL DISCOMFORT 160 0.0010
458 PAIN IN JAW 27 0.0010
459 FOREIGN BODY IN THROAT 3 0.0010
460 FOOD CRAVING 5 0.0009
461 DRUG ABUSE 79 0.0009
462 BLADDER PAIN 3 0.0009
463 RENAL PAIN 10 0.0009
464 INCREASED APPETITE 18 0.0009
465 HYPERSOMNIA 27 0.0009
466 DRY MOUTH 75 0.0009
467 ANGINA UNSTABLE 6 0.0009
468 HEPATITIS ACUTE 6 0.0009
469 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
470 MYOCLONUS 11 0.0009
471 MUSCLE RIGIDITY 11 0.0009
472 HEAD DISCOMFORT 16 0.0009
473 SALIVARY HYPERSECRETION 9 0.0009
474 HYPERTHYROIDISM 13 0.0009
475 LOSS OF LIBIDO 8 0.0009
476 DRUG INEFFECTIVE 1170 0.0009
477 UNEVALUABLE EVENT 67 0.0009
478 HEMIPARESIS 15 0.0009
479 SUSPECTED OFF LABEL USE 4 0.0009
480 HYPERHIDROSIS 114 0.0009
481 NERVOUSNESS 46 0.0009
482 IMPAIRED DRIVING ABILITY 10 0.0009
483 URINARY INCONTINENCE 26 0.0009
484 INFARCTION 6 0.0009
485 HAEMORRHAGE INTRACRANIAL 13 0.0009
486 COVID-19 152 0.0009
487 PRODUCT DISTRIBUTION ISSUE 8 0.0009
488 HALLUCINATION, VISUAL 18 0.0009
489 PRODUCT USE IN UNAPPROVED INDICATION 211 0.0009
490 LETHARGY 48 0.0008
491 TYPE 1 DIABETES MELLITUS 5 0.0008
492 GUILLAIN-BARRE SYNDROME 4 0.0008
493 CIRCULATORY COLLAPSE 14 0.0008
494 ABDOMINAL TENDERNESS 4 0.0008
495 PRODUCT QUALITY ISSUE 109 0.0008
496 BLEPHAROSPASM 5 0.0008
497 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
498 SUBARACHNOID HAEMORRHAGE 8 0.0008
499 ERECTILE DYSFUNCTION 20 0.0008
500 ANAL INCONTINENCE 7 0.0008
501 HEADACHE 485 0.0008
502 FAECES HARD 3 0.0008
503 WEIGHT DECREASED 215 0.0008
504 EXTRAPYRAMIDAL DISORDER 19 0.0008
505 PRODUCT ODOUR ABNORMAL 8 0.0008
506 CYANOSIS 12 0.0008
507 SOMNAMBULISM 5 0.0008
508 TREATMENT FAILURE 63 0.0008
509 BLOOD LACTIC ACID INCREASED 4 0.0008
510 DEPRESSED LEVEL OF CONSCIOUSNESS 30 0.0008
511 DISORIENTATION 30 0.0008
512 OBESITY 12 0.0008
513 EAR INFECTION 20 0.0008
514 PRODUCT SIZE ISSUE 4 0.0007
515 AMENORRHOEA 13 0.0007
516 CEREBROVASCULAR ACCIDENT 124 0.0007
517 EYE MOVEMENT DISORDER 5 0.0007
518 COGNITIVE DISORDER 34 0.0007
519 ENCEPHALITIS 5 0.0007
520 DELIRIUM 25 0.0007
521 MENTAL STATUS CHANGES 20 0.0007
522 ORAL DISCOMFORT 10 0.0007
523 EXTRASYSTOLES 5 0.0007
524 DRUG USE DISORDER 6 0.0007
525 COELIAC DISEASE 7 0.0007
526 INTESTINAL STENOSIS 3 0.0007
527 FACIAL PARALYSIS 6 0.0007
528 BACTERIAL INFECTION 13 0.0007
529 DRUG DEPENDENCE 110 0.0007
530 LYMPHOCYTE COUNT DECREASED 12 0.0007
531 BLOOD CREATINE INCREASED 3 0.0007
532 SINUS HEADACHE 4 0.0007
533 SYMPTOM RECURRENCE 4 0.0007
534 FATIGUE 518 0.0007
535 PRODUCT TASTE ABNORMAL 9 0.0007
536 URINARY RETENTION 22 0.0007
537 MEMORY IMPAIRMENT 90 0.0007
538 EPILEPSY 20 0.0007
539 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
540 ABNORMAL DREAMS 18 0.0007
541 PREGNANCY 13 0.0006
542 MULTIPLE ALLERGIES 5 0.0006
543 HALLUCINATION 48 0.0006
544 GASTROINTESTINAL PAIN 7 0.0006
545 BLOOD PROLACTIN INCREASED 3 0.0006
546 SEASONAL ALLERGY 9 0.0006
547 HYPERTENSIVE CRISIS 7 0.0006
548 VISION BLURRED 86 0.0006
549 SENSORY DISTURBANCE 10 0.0006
550 GALACTORRHOEA 4 0.0006
551 TREMOR 103 0.0006
552 ERUCTATION 12 0.0006
553 DECREASED APPETITE 144 0.0006
554 UNRESPONSIVE TO STIMULI 16 0.0006
555 SYNCOPE 62 0.0006
556 INCOHERENT 4 0.0006
557 HYPERPROLACTINAEMIA 4 0.0006
558 PRESYNCOPE 15 0.0006
559 SUBSTANCE ABUSE 5 0.0006
560 THERAPY CHANGE 6 0.0006
561 PRODUCT PREPARATION ISSUE 4 0.0006
562 BEDRIDDEN 8 0.0006
563 PHOTOSENSITIVITY REACTION 10 0.0006
564 TARDIVE DYSKINESIA 17 0.0006
565 BRAIN INJURY 6 0.0006
566 SPLENOMEGALY 7 0.0006
567 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
568 PRODUCT PRESCRIBING ISSUE 13 0.0006
569 INTENTIONAL DOSE OMISSION 17 0.0006
570 FEEDING DISORDER 12 0.0006
571 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
572 NEUROLEPTIC MALIGNANT SYNDROME 7 0.0006
573 PHOTOPHOBIA 11 0.0006
574 INCREASED UPPER AIRWAY SECRETION 3 0.0006
575 TEMPERATURE INTOLERANCE 6 0.0006
576 RESPIRATION ABNORMAL 4 0.0006
577 DRUG INTOLERANCE 56 0.0006
578 HYPERBILIRUBINAEMIA 6 0.0006
579 APLASTIC ANAEMIA 3 0.0006
580 LYMPHADENOPATHY 20 0.0006
581 CARDIAC ARREST 46 0.0006
582 HAEMATOCRIT DECREASED 11 0.0006
583 PARAESTHESIA ORAL 8 0.0006
584 OROPHARYNGEAL DISCOMFORT 5 0.0006
585 PALLOR 15 0.0006
586 ASPIRATION 6 0.0005
587 PSYCHIATRIC SYMPTOM 4 0.0005
588 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
589 HYPOPHOSPHATAEMIA 4 0.0005
590 SUNBURN 4 0.0005
591 MIDDLE INSOMNIA 10 0.0005
592 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
593 CEREBRAL INFARCTION 13 0.0005
594 ABORTION INDUCED 5 0.0005
595 LOSS OF CONSCIOUSNESS 68 0.0005
596 DYSMENORRHOEA 7 0.0005
597 CHEST DISCOMFORT 54 0.0005
598 DERMATITIS 11 0.0005
599 FEELING HOT 32 0.0005
600 EXERCISE TOLERANCE DECREASED 3 0.0005
601 FOOD ALLERGY 4 0.0005
602 HYPERVENTILATION 3 0.0005
603 ORTHOSTATIC HYPOTENSION 9 0.0005
604 CONCUSSION 4 0.0005
605 EATING DISORDER 11 0.0005
606 TACHYPNOEA 7 0.0005
607 AUTOIMMUNE DISORDER 5 0.0005
608 HAEMATEMESIS 13 0.0005
609 PAIN IN EXTREMITY 151 0.0005
610 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
611 ENERGY INCREASED 3 0.0005
612 DRUG SCREEN POSITIVE 4 0.0005
613 PRODUCT DISPENSING ERROR 11 0.0005
614 PRODUCT PRESCRIBING ERROR 12 0.0005
615 GASTROINTESTINAL DISORDER 45 0.0005
616 PYREXIA 172 0.0005
617 LACTIC ACIDOSIS 16 0.0005
618 SEIZURE 57 0.0005
619 PANCREATITIS ACUTE 11 0.0005
620 LIMB DISCOMFORT 15 0.0005
621 EOSINOPHIL COUNT INCREASED 4 0.0005
622 TREATMENT NONCOMPLIANCE 26 0.0005
623 SENSATION OF FOREIGN BODY 4 0.0005
624 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
625 NECK PAIN 26 0.0005
626 ECONOMIC PROBLEM 7 0.0005
627 OESOPHAGITIS 5 0.0005
628 OVERDOSE 98 0.0005
629 DYSARTHRIA 17 0.0005
630 FOOT DEFORMITY 5 0.0005
631 RESPIRATORY RATE INCREASED 4 0.0005
632 EJECTION FRACTION DECREASED 7 0.0004
633 ENCEPHALOPATHY 11 0.0004
634 AMNESIA 29 0.0004
635 OCULAR DISCOMFORT 5 0.0004
636 PRODUCT USE COMPLAINT 7 0.0004
637 BODY TEMPERATURE INCREASED 9 0.0004
638 ABNORMAL LOSS OF WEIGHT 3 0.0004
639 PREMATURE DELIVERY 7 0.0004
640 MYOCARDITIS 5 0.0004
641 MOVEMENT DISORDER 14 0.0004
642 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
643 BRAIN NEOPLASM 4 0.0004
644 SKIN DISCOLOURATION 20 0.0004
645 INTENTIONAL PRODUCT MISUSE 38 0.0004
646 BLOOD GLUCOSE ABNORMAL 8 0.0004
647 AUTOIMMUNE HEPATITIS 3 0.0004
648 ELECTROLYTE IMBALANCE 5 0.0004
649 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
650 APPENDICITIS 4 0.0004
651 DEFAECATION URGENCY 3 0.0004
652 FLANK PAIN 4 0.0004
653 MATERNAL EXPOSURE DURING PREGNANCY 38 0.0004
654 OROPHARYNGEAL PAIN 39 0.0004
655 DIZZINESS 210 0.0004
656 PRODUCT PACKAGING ISSUE 4 0.0004
657 SLEEP APNOEA SYNDROME 8 0.0004
658 ANGINA PECTORIS 12 0.0004
659 ACCIDENT 5 0.0004
660 BLOOD PRESSURE FLUCTUATION 10 0.0004
661 CHEST PAIN 77 0.0004
662 HYPERTENSION 88 0.0004
663 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
664 BRADYCARDIA 22 0.0004
665 OFF LABEL USE 363 0.0004
666 HYPOKINESIA 6 0.0004
667 DIZZINESS POSTURAL 4 0.0004
668 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
669 DRUG WITHDRAWAL SYNDROME 36 0.0004
670 SCAR 7 0.0004
671 PHARYNGEAL SWELLING 4 0.0004
672 ILLNESS 42 0.0004
673 METABOLIC ACIDOSIS 13 0.0004
674 WEIGHT INCREASED 91 0.0004
675 ROAD TRAFFIC ACCIDENT 17 0.0004
676 BODY TEMPERATURE DECREASED 4 0.0004
677 HYPOAESTHESIA 60 0.0004
678 COMA 19 0.0004
679 COLITIS 15 0.0004
680 PRODUCT DOSE OMISSION ISSUE 116 0.0004
681 ACIDOSIS 3 0.0004
682 BLOOD PRESSURE INCREASED 60 0.0004
683 THIRST 7 0.0004
684 BLOOD PRESSURE DECREASED 26 0.0004
685 ADVERSE EVENT 36 0.0004
686 HYPOKALAEMIA 18 0.0004
687 ANKLE FRACTURE 6 0.0004
688 APHTHOUS ULCER 3 0.0004
689 BLOOD CHOLESTEROL INCREASED 18 0.0004
690 APNOEA 3 0.0004
691 PULMONARY OEDEMA 17 0.0004
692 HYPOTENSION 76 0.0004
693 RASH 165 0.0004
694 JOINT DISLOCATION 4 0.0004
695 HEPATIC STEATOSIS 7 0.0004
696 SURGERY 22 0.0004
697 NAUSEA 294 0.0004
698 DECREASED ACTIVITY 4 0.0004
699 MYALGIA 63 0.0004
700 THERAPY CESSATION 19 0.0004
701 PHARYNGITIS STREPTOCOCCAL 4 0.0004
702 IMPAIRED GASTRIC EMPTYING 5 0.0004
703 EYE DISORDER 12 0.0004
704 EMBOLISM 3 0.0004
705 NO ADVERSE EVENT 65 0.0004
706 ORAL PAIN 8 0.0004
707 FISTULA 4 0.0004
708 CANDIDA INFECTION 6 0.0004
709 SKIN REACTION 5 0.0004
710 CARDIOVASCULAR DISORDER 9 0.0004
711 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
712 HEPATITIS 9 0.0004
713 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 71 0.0004
714 RED BLOOD CELL COUNT DECREASED 10 0.0003
715 PARALYSIS 5 0.0003
716 EXTRA DOSE ADMINISTERED 14 0.0003
717 TASTE DISORDER 7 0.0003
718 HYPOTHYROIDISM 11 0.0003
719 ANHEDONIA 9 0.0003
720 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
721 MUSCLE SPASMS 62 0.0003
722 BLOOD IRON DECREASED 4 0.0003
723 RHABDOMYOLYSIS 14 0.0003
724 RASH ERYTHEMATOUS 16 0.0003
725 GASTROENTERITIS VIRAL 6 0.0003
726 HYPOAESTHESIA ORAL 5 0.0003
727 VIRAL INFECTION 11 0.0003
728 EMOTIONAL DISTRESS 40 0.0003
729 FIBROMYALGIA 8 0.0003
730 HIDRADENITIS 3 0.0003
731 DISCOMFORT 20 0.0003
732 FLUSHING 33 0.0003
733 ABORTION SPONTANEOUS 13 0.0003
734 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
735 CONJUNCTIVITIS 6 0.0003
736 VAGINAL HAEMORRHAGE 14 0.0003
737 DIARRHOEA HAEMORRHAGIC 3 0.0003
738 ARTERIOSCLEROSIS 3 0.0003
739 PAIN 195 0.0003
740 EYE INFLAMMATION 3 0.0003
741 ULCER 5 0.0003
742 HYPOXIA 11 0.0003
743 ACUTE RESPIRATORY FAILURE 6 0.0003
744 PRESCRIBED OVERDOSE 6 0.0003
745 HEART RATE IRREGULAR 7 0.0003
746 EAR PAIN 6 0.0003
747 EMBEDDED DEVICE 3 0.0003
748 SARS-COV-2 TEST POSITIVE 4 0.0003
749 C-REACTIVE PROTEIN INCREASED 11 0.0003
750 BLADDER DISORDER 3 0.0003
751 BLOOD PRESSURE ABNORMAL 6 0.0003
752 DYSURIA 11 0.0003
753 MENSTRUATION IRREGULAR 8 0.0003
754 VISUAL IMPAIRMENT 37 0.0003
755 THROAT TIGHTNESS 8 0.0003
756 DRY THROAT 3 0.0003
757 DRUG LEVEL DECREASED 3 0.0003
758 ABDOMINAL PAIN 68 0.0003
759 DIABETES MELLITUS 22 0.0003
760 NERVOUS SYSTEM DISORDER 9 0.0003
761 MOUTH ULCERATION 6 0.0003
762 FULL BLOOD COUNT ABNORMAL 3 0.0003
763 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
764 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
765 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
766 FLATULENCE 16 0.0003
767 RETCHING 6 0.0003
768 BREAST PAIN 3 0.0003
769 BODY HEIGHT DECREASED 3 0.0003
770 ISCHAEMIC STROKE 5 0.0003
771 LEUKOPENIA 14 0.0003
772 PARAESTHESIA 44 0.0003
773 HEREDITARY ANGIOEDEMA 3 0.0003
774 NIGHT SWEATS 9 0.0003
775 BALANCE DISORDER 24 0.0003
776 LEUKOCYTOSIS 5 0.0003
777 DYSPEPSIA 27 0.0003
778 MELAENA 6 0.0003
779 CARDIOMYOPATHY 4 0.0003
780 SKIN HAEMORRHAGE 4 0.0003
781 RESPIRATORY TRACT INFECTION 7 0.0003
782 ABDOMINAL DISTENSION 28 0.0003
783 CHROMATURIA 6 0.0003
784 PREMATURE BABY 8 0.0003
785 POLLAKIURIA 11 0.0003
786 FOOT FRACTURE 5 0.0003
787 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
788 MALAISE 114 0.0003
789 GLAUCOMA 5 0.0003
790 HYPERSENSITIVITY 48 0.0003
791 INCORRECT DOSE ADMINISTERED 59 0.0003
792 FOETAL EXPOSURE DURING PREGNANCY 21 0.0003
793 DYSPHONIA 15 0.0003
794 HAEMORRHOIDS 5 0.0003
795 HEART RATE DECREASED 9 0.0003
796 CHOKING 5 0.0003
797 HEAD INJURY 8 0.0003
798 FEELING COLD 7 0.0003
799 VOMITING 117 0.0002
800 HYPONATRAEMIA 14 0.0002
801 ABDOMINAL PAIN UPPER 51 0.0002
802 PRODUCT ADMINISTRATION ERROR 5 0.0002
803 ASTHENIA 93 0.0002
804 THROAT IRRITATION 11 0.0002
805 THERAPY NON-RESPONDER 11 0.0002
806 LIVER INJURY 6 0.0002
807 EXPOSURE DURING PREGNANCY 15 0.0002
808 COAGULOPATHY 4 0.0002
809 DYSSTASIA 7 0.0002
810 ACUTE MYOCARDIAL INFARCTION 7 0.0002
811 ANAPHYLACTIC REACTION 13 0.0002
812 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
813 IRRITABLE BOWEL SYNDROME 5 0.0002
814 MUSCULOSKELETAL DISCOMFORT 4 0.0002
815 LACRIMATION INCREASED 7 0.0002
816 INJECTION SITE RASH 7 0.0002
817 GASTRITIS 6 0.0002
818 GYNAECOMASTIA 7 0.0002
819 GLOSSODYNIA 5 0.0002
820 JAUNDICE 6 0.0002
821 RASH PRURITIC 12 0.0002
822 TOOTHACHE 4 0.0002
823 CONSTIPATION 48 0.0002
824 SKIN LESION 6 0.0002
825 NEPHROLITHIASIS 10 0.0002
826 URTICARIA 36 0.0002
827 WOUND 6 0.0002
828 CHOLELITHIASIS 7 0.0002
829 SKIN EXFOLIATION 18 0.0002
830 EYE PAIN 12 0.0002
831 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
832 MUSCULAR WEAKNESS 24 0.0002
833 ACNE 16 0.0002
834 DERMATITIS ATOPIC 11 0.0002
835 NEURALGIA 5 0.0002
836 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
837 DRY EYE 10 0.0002
838 HEPATIC FAILURE 6 0.0002
839 CONTUSION 19 0.0002
840 HYPOPHAGIA 5 0.0002
841 CEREBRAL HAEMORRHAGE 7 0.0002
842 DRUG RESISTANCE 5 0.0002
843 INFLAMMATION 10 0.0002
844 DIPLOPIA 5 0.0002
845 GENERAL PHYSICAL HEALTH DETERIORATION 22 0.0002
846 DYSPNOEA 106 0.0002
847 INTESTINAL OBSTRUCTION 7 0.0002
848 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
849 DEPENDENCE 10 0.0002
850 HOSPITALISATION 28 0.0002
851 SKIN BURNING SENSATION 13 0.0002
852 BACK PAIN 42 0.0002
853 TRANSAMINASES INCREASED 4 0.0002
854 FACE OEDEMA 3 0.0002
855 PSORIATIC ARTHROPATHY 7 0.0002
856 BLINDNESS 7 0.0002
857 MUSCULOSKELETAL STIFFNESS 15 0.0002
858 EOSINOPHILIA 3 0.0002
859 RHINORRHOEA 11 0.0002
860 ASTHMA 19 0.0002
861 BLOOD GLUCOSE DECREASED 8 0.0002
862 BLOOD POTASSIUM DECREASED 5 0.0002
863 OEDEMA 9 0.0002
864 COMPLICATION OF DEVICE REMOVAL 3 0.0002
865 DEHYDRATION 22 0.0002
866 ILL-DEFINED DISORDER 10 0.0002
867 UNDERDOSE 12 0.0002
868 PRURITUS 63 0.0002
869 OXYGEN SATURATION DECREASED 9 0.0002
870 ABDOMINAL PAIN LOWER 4 0.0002
871 PRODUCT COMPLAINT 4 0.0002
872 SINUSITIS 16 0.0002
873 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
874 HERNIA 3 0.0002
875 ANAPHYLACTIC SHOCK 4 0.0002
876 HAEMATOMA 4 0.0002
877 EXPOSURE VIA SKIN CONTACT 4 0.0002
878 ARTHRALGIA 64 0.0002
879 SWELLING FACE 10 0.0002
880 CHILLS 18 0.0002
881 INFLUENZA 17 0.0002
882 PANCREATITIS 8 0.0002
883 NEOPLASM MALIGNANT 10 0.0001
884 GAIT INABILITY 5 0.0001
885 SWELLING 14 0.0001
886 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
887 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
888 RENAL FAILURE 19 0.0001
889 RASH MACULAR 5 0.0001
890 BLISTER 8 0.0001
891 MOBILITY DECREASED 10 0.0001
892 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
893 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
894 DRY SKIN 18 0.0001
895 HEPATOTOXICITY 3 0.0001
896 INFLUENZA LIKE ILLNESS 11 0.0001
897 HEPATIC ENZYME INCREASED 9 0.0001
898 GAIT DISTURBANCE 25 0.0001
899 INJURY 9 0.0001
900 DISEASE RECURRENCE 6 0.0001
901 MULTIPLE SCLEROSIS 6 0.0001
902 NASOPHARYNGITIS 23 0.0001
903 HAEMORRHAGE 13 0.0001
904 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
905 DEVICE BREAKAGE 5 0.0001
906 ALOPECIA 24 0.0001
907 BRONCHITIS 9 0.0001
908 STAPHYLOCOCCAL INFECTION 4 0.0001
909 DIARRHOEA 78 0.0001
910 MYOCARDIAL INFARCTION 21 0.0001
911 SKIN DISORDER 4 0.0001
912 CELLULITIS 6 0.0001
913 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
914 WHEEZING 7 0.0001
915 PERIPHERAL SWELLING 18 0.0001
916 ERYTHEMA 24 0.0001
917 DYSPHAGIA 11 0.0001
918 STOMATITIS 7 0.0001
919 DEAFNESS 3 0.0001
920 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
921 THROMBOSIS 9 0.0001
922 URINARY TRACT INFECTION 19 0.0001
923 DRUG EFFECT INCOMPLETE 4 0.0001
924 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
925 HYPERGLYCAEMIA 4 0.0001
926 RESPIRATORY FAILURE 8 0.0001
927 ARTHROPATHY 6 0.0001
928 EYE SWELLING 4 0.0001
929 COUGH 30 0.0001
930 CARDIAC DISORDER 10 0.0001
931 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
932 HYPOGLYCAEMIA 5 0.0001
933 PRODUCT STORAGE ERROR 9 0.0001
934 NASAL CONGESTION 6 0.0001
935 BURNING SENSATION 7 0.0001
936 CARDIAC FAILURE 8 0.0001
937 JOINT SWELLING 12 0.0001
938 OEDEMA PERIPHERAL 12 0.0001
939 HAEMOGLOBIN DECREASED 10 0.0001
940 OSTEOPOROSIS 4 0.0001
941 EPISTAXIS 7 0.0001
942 FALL 31 0.0001
943 HYPOACUSIS 4 0.0001
944 BLOOD CREATININE INCREASED 6 0.0001
945 INFUSION RELATED REACTION 6 0.0001
946 ANGIOEDEMA 4 0.0001
947 FUNGAL INFECTION 3 0.0001
948 EYE PRURITUS 3 0.0001
949 HAEMATURIA 3 0.0001
950 SKIN IRRITATION 4 0.0001
951 EYE IRRITATION 5 0.0001
952 OCULAR HYPERAEMIA 4 0.0001
953 PSORIASIS 11 0.0001
954 DYSPNOEA EXERTIONAL 3 0.0001
955 HOT FLUSH 6 0.0001
956 INJECTION SITE SWELLING 6 0.0001
957 PNEUMONIA 25 0.0001
958 CONVULSION 4 0.0001
959 DEVICE LEAKAGE 3 0.0001
960 DEVICE DISLOCATION 3 0.0001
961 BONE PAIN 4 0.0001
962 NEUTROPENIA 9 0.0001
963 NEUROPATHY PERIPHERAL 6 0.0001
964 SEPSIS 7 0.0001
965 INFECTION 9 0.0001
966 RHEUMATOID ARTHRITIS 7 0.0001
967 ATRIAL FIBRILLATION 6 0.0001
968 INJECTION SITE PRURITUS 4 0.0001
969 FLUID RETENTION 3 0.0001
970 ACUTE KIDNEY INJURY 9 0.0001
971 BLOOD GLUCOSE INCREASED 11 0.0001
972 BREAST CANCER 5 0.0001
973 HERPES ZOSTER 3 0.0001
974 INJECTION SITE PAIN 16 0.0001
975 CATARACT 3 0.0001
976 INJECTION SITE BRUISING 4 0.0001
977 INJECTION SITE ERYTHEMA 6 0.0000
978 THROMBOCYTOPENIA 5 0.0000
979 DISEASE PROGRESSION 5 0.0000
980 DRUG DOSE OMISSION BY DEVICE 3 0.0000
981 CARDIAC FAILURE CONGESTIVE 3 0.0000
982 DEATH 31 0.0000
983 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
984 DEVICE ISSUE 3 0.0000
985 ANAEMIA 6 0.0000
986 DRUG DOSE OMISSION 5 0.0000